Home » Newsletters » BioWorld MedTech

BioWorld MedTech

June 23, 2010

View Archived Issues

FDA to accept PMA filing for ev3's embolization device

Report from Europe: Skyline licenses TrovaGene's NMP1 technology for product

Washington roundup: HHS offers $250 million for prevention despite iffy data

Court report: Spectranetics to pay $8.5M to settle upcoming litigation

MDD's food for med-tech thought

MDD/BioWorld win SIPA awards for book, series

Financings roundup: Covidien prices offering for its ev3 acquisition

Agreements/contracts: Mayo Clinic, U. of Illinois compose research alliance

New ventures: BTT says new technology will 'transform' temp measurement

Grants roundup: Apollo Endosurgery gets $5M for new GI cancer applications

Product Briefs

People in the News

MDD's Oncology Extra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 4, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
ADPD 2025: Unlocking GLP-1's potential in neurodegeneration
BioWorld
At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...
Checkpoint inhibitor journey traces Chinese firms’ path to global revenue
BioWorld
Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...